Record date 9th Sept, page-89

First 89 Last

Share
Profile

Follow
Venus401

45 Posts.

7

14/09/20

07:58

Post #: 47308466
Share

Originally posted by BoosterGold: ↑

Wow what a clusterf**k of a thread, just what’s being discussed, a lot of people have no clue and should probably do some research themselves before jumping the gun.

Just to simplify:
•Needed to hold shares going into Trading Halt to be “entitled” to the 1 for 6.5 at $6.50 offer

•You will be sent documents to exercise your rights from Friday, you can find these in your computershare account too (if you’d like quick access) don’t need to panic all over the forums about this.

•PBHRA - there’s really no reason to be buying these, like mentioned here, this isn’t a stock, it’s a ‘right to buy’ a stock, you pay for the right, you then need to pay for the stock, at the moment these are overvalued as you can buy the actual stock cheaper on market and actually have the stock.
Your biggest risk with these is them being worth zero, the closer that PBH gets to $6.50 the less valuable these become, on today’s closing price of PBH these are technically worth about $4.54 (not the $6.40 they closed at)
Also if you buy these and then take no action, you will lose whatever you spent on them as these pretty much self terminate on the 22nd of September (worth $0 and unreadable)

•Free Options, want to touch on this too, like PBHRA, the options will be tradable when we get them (Most likely as PBHO) if you’re going to be buying these, remember in order to turn them into shares You will need to pay an additional $13 per option to make it a share, but you will have a lot longer than the rights that are currently trading.

Today was a down day for multiple reasons:
•Ex entitlement yes
•All tech stocks been smacked while PBH was in a trading halt, so they kinda needed to catch up on the discounting the stock

Should see green tomorrow, US markets (inc nasdaq) looking a lot better

Expand

Thanks for taking the time to explain..

PBH Price at posting: $10.92 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HAS

Hastings progressing Yangibana to production with lower costs

There are more pages in this discussion • 28 more messages in this thread...

First 89 Last

Add PBH (ASX) to my watchlist

(20min delay)
Last 70.0¢		Change 0.000(0.00%)		Mkt cap ! $231.9M

Open	High	Low	Value	Volume
70.0¢	71.0¢	67.8¢	$687.4K	992.0K

Buyers (Bids)

No.	Vol.	Price($)
1	31912	69.0¢

Sellers (Offers)

Price($)	Vol.	No.
70.0¢	16383	3

View Market Depth

No.	Vol.	Price($)
1	31912	0.690
3	21780	0.685
6	47160	0.680
2	46761	0.675
2	2955	0.670

Price($)	Vol.	No.
0.700	16383	3
0.705	13780	1
0.710	37161	3
0.720	16461	2
0.730	62524	4

Last trade - 16.10pm 30/09/2024 (20 minute delay)

PBH (ASX) Chart

Record date 9th Sept, page-89

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Record date 9th Sept, page-89

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News